Prevention

Better organization can be more useful than compulsory vaccination

May 13, 2017

Mandatory vaccinations for both healthcare workers and the public can obtain a rapid improvement in immunization rates, but in the end have high cost, especially in term of litigation. The same results can be achieved putting resources into better organization and communication programs. This is the opinion of Darina O’Flanagan, previous Director of Health Protection Surveillance Centre Ireland and a member of the Advisory Forum of the European Centre for Disease Control since its inception in 2005 up to 2016. She was also one of the founder partners of the European Vaccine Network VENICE and is participating to Pandem project, on behalf of the WHO Regional Office for Europe.

Target: 
Government and Public Health, Healthcare Professionals
Topic: 
Prevention, Stakeholders, Vaccination
Tags: 
Video, Vaccine, science-in-society, public health communication

Compulsory vaccination in healthcare workers

Tuesday, May 9, 2017 - 16:18

In front of low rates of immunization, many claim for compulsory vaccination, especially as far as healthcare workers are concerned. Their institutional role and ethical purpose is to take care of a subgroup of citizens particularly weak, because of their health conditions. This is always true, but even more when immunocompromised or frail patients, vulnerable to infections, are involved. All healthcare workers have therefore a moral duty not to hurt people they have to take care of, following the ancient principle “Primum non nocere”.

Target: 
Government and Public Health, Healthcare Professionals
Topic: 
Policy, Prevention, Vaccination
Tags: 
Vaccine, Health care workers, public health

Global concerns regarding novel influenza A (H7N9) virus infections

Uyeki TM, Cox NJ. N Engl J Med. May 16, 2013. 

Target: 
Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Prevention
Tags: 
influenza, H7N9, pandemic risk assessment

Major challenges in providing an effective and timely pandemic vaccine for influenza A(H7N9)

Osterholm MT, Ballering KS, Kelley NS. JAMA. On line May 9, 2013.

Target: 
Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Prevention
Tags: 
influenza, H7N9, pandemic, Vaccine

Infezione da virus influenzale HTN9 nell'uomo in Cina

Italian Ministry of Health. 2013 May 3. Infezione da virus influenzale HTN9 nell'uomo in Cina.

Target: 
Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Prevention

Third edition of the ASSET best practice award for general practitioners

Monday, February 27, 2017 - 18:33

ASSET AIM

ASSET – Action Plan on SiS Related Issues in Epidemics and Total Pandemics is a 4-year FP7 EU co funded project which aims to:   

Target: 
Healthcare Professionals
Topic: 
Human Rights, Local Activities, Prevention, Stakeholders
Tags: 
award, science-in-society

The winners for the ASSET best practice award

Thursday, February 23, 2017 - 16:30

The second edition of the ASSET best practice award for general practitioners has come to an end, with the assignment of the four grants to health professionals or groups of health professionals working in the primary health sector.

Target: 
Healthcare Professionals
Topic: 
Gender, Human Rights, Local Activities, Prevention, Stakeholders, Vaccination
Tags: 
gender issues, Vaccine, Vaccine hesitancy, Vaccine safety, Roma, Pregnancy

Towards an extension of mandatory vaccination in Italy?

Monday, February 6, 2017 - 10:44

Immunization rates in Italy are decreasing at a worrying trend: international targets for measles eradication and safety thresholds in childhood vaccination are vanishing. Authorities, doctors and families are concerned that a coverage below 86% for MPR (measles, parotitis and rubella) vaccine can impair herd immunity, putting younger babies, immunocompromised people and not-responders at risk.

Target: 
Citizens, Government and Public Health, Healthcare Professionals, School and Education
Topic: 
Prevention, Stakeholders, Vaccination
Tags: 
Vaccine, Vaccine hesitancy, Vaccine safety, communication, engagement, public health

Sex, clinical trials and medicines regulation part II

Friday, December 30, 2016 - 10:24

Drug Approval Regulation in Canada and USA

Since the thalidomide tragedy in the late1950s, there has been a reluctance to include women of childbearing age in clinical trials. However, this fear cannot be used as an excuse to not include females in clinical trials, and, with proper care and regulation, increased female participation has been reached. The United States adopted regulation early on to increase the participation of women, while a new regulation in Europe is going to improve this as well. Here follows an overview of the issue in Canada and in the USA. The third part of this series will deal with new regulation in Europe.

Target: 
Decision Makers, Government and Public Health
Topic: 
Gender, Prevention, Stakeholders, Treatment, Vaccination
Tags: 
gender issues, clinical trials

Flu Effect on the web: an Italian analysis on influenza and vaccination

Thursday, December 29, 2016 - 09:01

The internet deals a lot with flu, but mostly talks about care and little about prevention. This is the result of a study made by Voices from the Blogs, a spin-off of the University of Milan, on the web-sentiment on influenza and vaccination in Italy.

Target: 
Citizens, School and Education
Topic: 
Prevention, Social Media, Vaccination
Tags: 
flu, influenza, Vaccine, Vaccine safety, Social media

Pages

Subscribe to Prevention

MMLAP and other EU Projects

AsiaFluCap
Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia
BEWATER
Making society an active participant in water adaptation to global change
CASI
Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation
CIMULACT
Engaging all of Europe in shaping a desirable and sustainable future
DARWIN
Expect the unexpected and know how to respond
DRIVER
Driving innovation in crisis management for European resilience
ECOM
Effective communication in outbreak management: development of an evidence-based tool for Europe
EDEN
Solutions to improve CBRNe resilience
EPISOUTH
Network for Communicable Disease Control in Southern Europe and Mediterranean Countries
EPIWORK
Developing the framework for an epidemic forecast infrastructure
EUPHARE
Strengthening of the national surveillance system for communicable diseases
EUROHEP
Surveillance of vaccine preventable hepatitis
EuroMOMO
European monitoring of excess mortality for public health action
EURONHID
European network for highly infectious disease
EUVAC.NET
Dedicated surveillance network for surveillance and control of vaccine preventable diseases in the EU
FLUMODCONT
Modelling the spread of pandemic influenza and strategies for its containment and mitigation
FLURESP
Cost-effectiveness assessment of european influenza human pandemic alert and response strategies
GAP2
Bridging the gap between science, stakeholders and policy makers
HProImmune
Promotion of immunization for health professionals in Europe
INPROFOOD
Towards inclusive research programming for sustainable food innovations
JA-CHRODIS
Addressing chronic diseases and healthy ageing across the life cycle
M-Eco
Medical ecosystem – personalized event-based surveillance
MAPPING
Studying the many and varied economic, social, legal and ethical aspects of the recent developments on the Internet, and their consequences for the individual and society at large
MARINA
Get involved in the responsible marine research and innovation
PACITA
Knowledge-based policy-making on issues involving science, technology and innovation, mainly based upon the practices in Parliamentary Technology Assessment
PANDEM
Assessment of the current pandemic preparedness and response tools, systems and practice at national, EU and global level in priority areas
PE2020
Analysis of innovative public engagement tools and instruments for dynamic governance in the field of Science in Society
PERARES
Public Engagement with Research And Research Engagement with Society
PHEME
Computing Veracity – the Fourth Challenge of Big Data
PREPARE
Providing infrastructure, co-ordination and integration of existing clinical research networks on epidemics and pandemics
PROMOVAX
Promote vaccinations among migrant population in Europe
R&DIALOGUE
Creating mechanisms for effectively tackling the scientific and technology related challenges faced by society
RESPIRE
Improve the quality of indoor air, keeping it free from radon
SATORI
Improving respect of ethics principles and laws in research and innovation, in line with the evolution of technologies and societal concerns
SECURING CITIES AGAINST GLOBAL PANDEMICS
Investigating how cities in the West securitise against global pandemics
SEiSMiC
Creating a structured dialogue and mutual learning with citizens and urban actors by setting up National Networks in 10 countries across Europe
SIS CATALYST
Identifying how children can be change agents in the Science and Society relationship
SYN-ENERGENE
Establishing an open dialogue between stakeholders concerning synthetic biology’s potential benefits and risks
TELLME
Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence